GUIDE PPE - Cyprus Organization for the Promotion of Quality
GUIDE PPE - Cyprus Organization for the Promotion of Quality
GUIDE PPE - Cyprus Organization for the Promotion of Quality
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Guide on <strong>PPE</strong> Directive<br />
EuropeAid /114385/D/SV/CY<br />
with <strong>the</strong> per<strong>for</strong>mance levels claimed by <strong>the</strong> manufacturer, it is generally not possible to reach a conclusion<br />
simply by visual examination. Checking technical con<strong>for</strong>mity <strong>of</strong> <strong>PPE</strong> requires carrying out laboratory tests.<br />
CHECKING COMPLIANCE WITH ESSENTIAL HEALTH AND SAFETY REQUIREMENTS<br />
The tests necessary to check compliance with EHSRs are <strong>of</strong>ten destructive, and may require several<br />
samples <strong>of</strong> <strong>the</strong> <strong>PPE</strong> concerned. So this aspect <strong>of</strong> market surveillance involves ei<strong>the</strong>r <strong>the</strong> taking or <strong>the</strong><br />
purchase <strong>of</strong> <strong>the</strong> required number <strong>of</strong> samples (depending on <strong>the</strong> surveillance authorities’ powers). Tests<br />
may be carried out within <strong>the</strong> authorities own facilities when <strong>the</strong>se are available, or else entrusted to<br />
competent laboratories.<br />
In general, when <strong>the</strong> type <strong>of</strong> <strong>PPE</strong> concerned is covered by harmonized standards, <strong>the</strong> appropriate tests<br />
are those described in <strong>the</strong> relevant standard. If no harmonized standard exists, or if <strong>the</strong> manufacturer has<br />
applied o<strong>the</strong>r criteria <strong>for</strong> con<strong>for</strong>mity evaluation, it may be necessary to determine appropriate tests. In<br />
many cases, it may be considered unnecessary to carry out all <strong>the</strong> tests laid down by <strong>the</strong> harmonized<br />
standard. Time and money may be saved by limiting <strong>the</strong> checks to test with particular importance <strong>for</strong> <strong>the</strong><br />
safety <strong>of</strong> users, or sufficient to determine <strong>the</strong> level <strong>of</strong> protection af<strong>for</strong>ded by <strong>the</strong> <strong>PPE</strong>.<br />
In many cases <strong>the</strong> laboratories most competent and best equipped to carry out <strong>the</strong> tests are <strong>the</strong><br />
laboratories <strong>of</strong> Notified Bodies, but it must be clear that in this case <strong>the</strong> body is not acting as a NB but as a<br />
test-house on behalf <strong>of</strong> <strong>the</strong> market surveillance authorities.<br />
When <strong>the</strong> market surveillance authorities receive <strong>the</strong> test reports, manufacturers should whenever<br />
possible be in<strong>for</strong>med <strong>of</strong> <strong>the</strong> results and asked to present <strong>the</strong>ir observations, be<strong>for</strong>e action is decided.<br />
Exceptions may be justified, if action is considered urgent to protect <strong>the</strong> safety <strong>of</strong> users.<br />
Experience shows that in most cases, when market surveillance checks reveal anomalies, corrective<br />
measures are agreed by <strong>the</strong> manufacturer. These corrective measures may include completion <strong>of</strong> <strong>the</strong><br />
con<strong>for</strong>mity evaluation procedure, modifications concerning <strong>the</strong> product and <strong>the</strong> instructions <strong>for</strong> use, or<br />
improvement <strong>of</strong> <strong>the</strong> arrangements <strong>for</strong> quality control <strong>of</strong> <strong>the</strong> production. When surveillance reveals<br />
substantial problems concerning ei<strong>the</strong>r <strong>the</strong> <strong>PPE</strong> itself or <strong>the</strong> in<strong>for</strong>mation supplied to users, manufacturers<br />
may be asked to withdraw products from <strong>the</strong> market and/or in<strong>for</strong>m <strong>the</strong>ir customers.<br />
In <strong>the</strong> case <strong>of</strong> noncompliant <strong>PPE</strong>, after taking into account <strong>the</strong> observations presented by manufacturers,<br />
and in light <strong>of</strong> <strong>the</strong> seriousness <strong>of</strong> <strong>the</strong> non-compliance, <strong>the</strong> market surveillance authorities have to<br />
determine <strong>the</strong> appropriate course <strong>of</strong> action. Several possibilities are open.<br />
IF ADEQUATE CORRECTIVE MEASURES ARE AGREED BY THE MANUFACTURER<br />
When <strong>the</strong> manufacturer and <strong>the</strong> authorities agree on corrective measures, and <strong>the</strong>se are considered<br />
sufficient to protect <strong>the</strong> health and safety <strong>of</strong> users provided sufficient assurance is given that <strong>the</strong>se<br />
measures will effectively be carried out, <strong>the</strong> market surveillance authorities may consider <strong>the</strong> file to be<br />
closed. In <strong>the</strong> majority <strong>of</strong> cases this outcome is doubtful.<br />
This situation raises a problem, since technical harmonization introduced by <strong>the</strong> directive has created a<br />
single market enabling <strong>PPE</strong> to move freely across national borders, but <strong>the</strong> market surveillance authority<br />
is competent only <strong>for</strong> <strong>the</strong> national market. If a problem has reached a satisfactory solution in one Member<br />
State, an unscrupulous manufacturer may be tempted to sell <strong>of</strong>f noncompliant stock in o<strong>the</strong>r Member<br />
States where <strong>the</strong> problem may not be detected.